Root cause investigation of a viral contamination incident occurred during master cell bank (MCB) testing and characterization - A case study

Biologicals

Volumn 36, Issue 6, 2008, Pages 393-402

  Chen, Dayue ^a   Nims, Raymond ^b   Dusing, Sandra ^b   Miller, Pamela ^b   Luo, Wen ^a   Quertinmont, Michelle ^a   Parekh, Bhavin ^a   Poorbaugh, Josh ^a   Boose, Jeri Ann ^b   Atkinson, E Morrey ^a  

^a ELI LILLY AND COMPANY   (United States)

^b BioReliance   (United States)

Author keywords

Adventitious agent testing; Equine rhinitis A virus; Investigation; Master cell bank testing; Viral contamination

Indexed keywords

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; LIFE CYCLE; MOLECULAR CLONING; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; RHINOVIRUS; SCREENING; TRANSMISSION ELECTRON MICROSCOPY; VIRAL CONTAMINATION;

ANIMALS; APHTHOVIRUS; BIOLOGICAL PRODUCTS; BIOTECHNOLOGY; CATTLE; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; CRICETULUS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, TRANSMISSION; PICORNAVIRIDAE; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; VERO CELLS;

BOVINAE; CRICETULUS GRISEUS; EQUIDAE; EQUINE RHINITIS A VIRUS; PICORNAVIRIDAE; RHINOVIRUS;

EID: 56949098614     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2008.07.005     Document Type: Article

References (23)

1. Code of Federal Regulations, title 9 part 113 section 53. Requirements for ingredients of animal origin used for production of biologics (2006), US Government Printing Office p. 644-5
2. Code of Federal Regulations, title 9 part 113 section 46. Detection of cytopathogenic and/or hemadsorbing agents (2006), US Government Printing Office p. 640
3. Code of Federal Regulations, title 9 part 113 section 47. Detection of extraneous viruses by the fluorescent antibody technique (2006), US Government Printing Office p. 640-1
4. EMEA: note for guidance on the use of bovine serum in the manufacture of human biological medicinal products (CPMP/BWP/1793/02). London; 2003. p. 1-8. Available at: .
5. Lennette E.H. General principles underlying laboratory diagnosis of viral and rickettsial infections. In: Lennette E.H., and Schmidt N.J. (Eds). Diagnostic procedures for viral and rickettsial infections. 4th ed. (1969), American Public Health Association, Inc., New York 1-65
6. Newman J.F., Rowlands D.J., and Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol 18 2 (1973) 171-180
7. Racaniello V.R. Picornaviridae. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia 685-722
8. Shepherd A.J., Wilson N.J., and Smith K.T. Characterization of endogenous retrovirus in rodent cell lines used for production of biologicals. Biologicals 31 (2003) 251-260
9. Dinowitz M., Lie Y.S., Low M.A., Lazar R., Fautz C., Potts B., et al. Recent studies on retrovirus-like particles in Chinese hamster ovary cells. Dev Biol Stand 76 (1992) 201-207
10. Hojman F., Emanoil-Raivier R., Lesser J., and Peries J. Biological and molecular characterization of an endogenous retrovirus present in CHO/HBs - a Chinese hamster cell line. Dev Biol Stand 70 (1989) 195-202
11. Poiley J.A., Nelson R.E., Hillesund T., and Raineri R. Susceptibility of CHO-K1 cells to infection by eight adventitious viruses and four retroviruses. In Vitro Toxicol 4 (1991) 1-12
12. Wiebe M.E., Becker F., Lazar R., May L., Casto B., Semense M., et al. A multifaceted approach to assure that recombinant tPA is free of adventitious virus. In: Spier R.E. (Ed). Advances in animal cell biology and technology for bioprocesses (1989), Butterworths, London 68-71
13. Garnick R.L. Experience with viral contamination in cell culture. Dev Biol Stand 88 (1996) 49-56
14. Nims R.W. Detection of adventitious viruses in biologicals - a rare occurrence. In: Petricciani J., and Sheets R. (Eds). Vaccine cell substrates vol. 123 (2004), Dev Biol 153-164
15. Nims RW, Dusing SK, Hsieh WT, Lovatt A, Reid GG, Onions D, et al. Detection of cache valley virus in biologics. Emerg Infect Dis, submitted for publication.
16. Rabenau H., Ohlinger V., Anderson J., Selb B., Citatl J., Wolf W., et al. Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). Biologicals 21 (1993) 207-214
17. Li F., Browning G.F., Studdert M.J., and Crabb B.S. Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Proc Natl Acad Sci U S A 93 (1996) 990-995
18. Wutz G., Auer H., Nowotny N., Grosse B., Skern T., and Kuechler E. Equine rhinovirus serotypes 1 and 2: relationship to each other and to aphthoviruses and cardioviruses. J Gen Virol 77 (1996) 1719-1730
19. O'Niell F.D., and Issel C.J. Growth kinetics of equine respiratory tract viruses in cell and organ cultures. Am J Vet Res 45 (1984) 1961-1966
20. Plummer G. An equine respiratory enterovirus. Some biological and physical properties. Arch Gesamte Virusforsch 12 (1963) 694-700
21. McCollum W.H., and Timoney P.J. Studies of the seroprevalence and frequency of equine rhinovirus-I and II infection in normal horse. In: Plowright W., Possdale P.D., and Wade J.F. (Eds). Equine infectious diseases VI (1992), R&W Publications, Newmarket, UK 83-87
22. Stevenson R.A., Huang J.A., Studdert M.J., and Hartley C.A. Sialic acid acts as a receptor for equine rhinitis A virus binding and infection. J Gen Virol 85 (2004) 2535-2543
23. Li F., Drummer H.E., Ficorilli N., Studdert M.J., and Crabb B.S. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses. J Clin Microbiol 35 4 (1997) 937-943